Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

FDA requires more clarity on informed consent forms for clinical trials

September 11, 2019 By Danielle Kirsh

By Stewart Eisenhart, Emergo Group

A recent survey conducted by the US Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) has revealed several areas in need of improvement, according to the agency.

Get the full story here at the Emergo Group’s blog.

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of DrugDeliveryBusiness.com or its employees.

Filed Under: Regulatory/Compliance Tagged With: blog, Emergo Group

IN CASE YOU MISSED IT

  • W.L. Gore officials think they can spur insulin delivery system innovation
  • Leo Pharma, Portal Instruments partner to develop needle-free drug delivery device
  • J&J’s Ethicon launches Vistaseal fibrin sealant
  • Senseonics launches Eversense CGM System with non-adjunctive claim
  • ‘Hubble Space Telescope’ for genomics could yield new drugs, materials
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookDrug Delivery Business News
Follow us on Twitter@DrugDeliveryNow
Connect with us on LinkedInLinkedIn

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS